NCT01546922View on ClinicalTrials.gov

Hydrocortisone Replacement in Patients With Secondary Adrenal Insufficiency (SUPREME CORT)

PHASE4CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Adrenal Insufficiency
Interventions
DRUG

Hydrocortisone

Patients receive either a low dose HC (0.2-0.3 mg/kg body weight) for 10 weeks followed by 10 weeks of high dose HC (0.4-0.6 mg/kg body weight) or vice versa.

Trial Locations (1)

9700RB

University Medical Centre Groningen, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT01546922 - Hydrocortisone Replacement in Patients With Secondary Adrenal Insufficiency (SUPREME CORT) | Biotech Hunter | Biotech Hunter